Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial
- 31 March 2010
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 11 (3), 258-265
- https://doi.org/10.1016/s1470-2045(10)70013-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?The Lancet Oncology, 2009
- Single Nucleotide Polymorphisms, Apoptosis, and the Development of Severe Late Adverse Effects After RadiotherapyClinical Cancer Research, 2008
- Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98Journal of Clinical Oncology, 2007
- Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathologyNature Reviews Cancer, 2006
- A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast CancerThe New England Journal of Medicine, 2005
- CD4 and CD8 T-Lymphocyte Apoptosis Can Predict Radiation-Induced Late Toxicity: A Prospective Study in 399 PatientsClinical Cancer Research, 2005
- Radiation Therapy and Tamoxifen: Concurrent or Sequential? It's No Longer the Question!Journal of Clinical Oncology, 2005
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- Effets tardifs de la radiothérapie mammaire sur la peau et les tissus sous-cutanésCancer/Radiothérapie, 1997
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993